What is Merck’s policy on clinical trials and patient safety?

At Merck, patient safety is our utmost priority during clinical trials. We adhere to strict ethical standards and rigorous protocols to safeguard the well-being of participants. Our policy strictly follows all applicable laws, regulations, and guidelines set by health authorities. We maintain transparency by providing detailed information about the trial, including its purpose, risks, and potential benefits, to ensure that participants can make informed decisions. Before conducting any trial, we obtain necessary approvals from regulatory bodies and ethics committees. We conduct thorough pre-clinical research and monitor trials carefully to identify and promptly address any adverse events or safety concerns. Our commitment to patient safety remains unwavering, ensuring that every individual involved in our clinical trials receives the utmost care and protection.